Codexis Inc Asset Resilience Ratio

Latest as of September 2025: 26.90%

Codexis Inc asset resilience ratio. Codexis Inc (CDXS) has an Asset Resilience Ratio of 26.90% as of September 2025. The Asset Resilience Ratio measures the percentage of a company's total assets that are held in liquid form (cash and short-term investments). This metric indicates how well-positioned the company is to handle unexpected financial challenges, economic downturns, or strategic opportunities without requiring external financing. See operational self-sufficiency of Codexis Inc to measure how many days the company can operate on defensive assets alone.

Liquid Assets

$33.35 Million

Cash + Short-term Investments

Total Assets

$123.96 Million

All company assets

Resilience Assessment

Very High

Financial Resilience Level

Asset Resilience Ratio of Codexis Inc (2007–2024)

Asset resilience ratio of Codexis Inc from 2007 to 2024. This chart shows how Codexis Inc's Asset Resilience Ratio has changed over time. Read CDXS current and long-term liabilities for a breakdown of total debt and financial obligations.

Liquid Assets Composition Over Time

This chart breaks down Codexis Inc's liquid assets into cash & equivalents and short-term investments, showing how the composition has evolved over time. For the complete balance sheet picture, see CDXS asset base.

Current Liquid Assets Breakdown

Component	Amount	% of Total Assets
Cash & Equivalents	$0.00	0%
Short-term Investments	$33.35 Million	26.9%
Total Liquid Assets	$33.35 Million	26.90%

Asset Resilience Insights

Very High Liquidity: Codexis Inc maintains exceptional liquid asset reserves at 26.90% of total assets.
This level provides strong protection against economic uncertainties but may indicate potential for more aggressive growth investments.
The company has significant short-term investments, indicating active treasury management.

Codexis Inc Industry Peers by Asset Resilience Ratio

Compare Codexis Inc's asset resilience ratio with other companies in the same industry.

Company	Industry	Asset Resilience Ratio
Madrigal Pharmaceuticals Inc NASDAQ:MDGL	Biotechnology	62.31%
Verona Pharma plc F:I9SA	Biotechnology	0.00%
Centessa Pharmaceuticals PLC ADR NASDAQ:CNTA	Biotechnology	33.37%
Shanghai RAAS Blood Products Co Ltd Class A SHE:002252	Biotechnology	2.03%
Beijing Tiantan Biological Products Corp Ltd SHG:600161	Biotechnology	8.08%
Bavarian Nordic CO:BAVA	Biotechnology	10.83%
Hebei Changshan Biochem Pharma SHE:300255	Biotechnology	-0.03%
Tibet Cheezheng Tibetan Medicine Co Ltd SHE:002287	Biotechnology	37.31%

Codexis Inc Asset Resilience Ratio by Year (2007–2024)

Codexis Inc asset resilience ratio by year from 2007 to 2024. The table below shows the annual Asset Resilience Ratio data for Codexis Inc.

Year	Asset Resilience Ratio (%)	Liquid Assets	Total Assets	Change
2024-12-31	36.37%	$54.19 Million	$149.01 Million	--
2023-12-31	0.00%	$0.00	$136.56 Million	--
2021-12-31	0.00%	$0.00	$246.38 Million	--
2020-12-31	0.45%	$1.00 Million	$221.65 Million	--
2017-12-31	0.00%	$0.00	$53.62 Million	--
2016-12-31	0.00%	$0.00	$35.65 Million	--
2015-12-31	0.00%	$0.00	$44.65 Million	--
2014-12-31	0.00%	$0.00	$48.12 Million	--
2013-12-31	5.11%	$3.00 Million	$58.84 Million	-8.42pp
2012-12-31	13.53%	$13.52 Million	$99.97 Million	-6.87pp
2011-12-31	20.39%	$27.72 Million	$135.92 Million	-3.62pp
2009-12-31	24.01%	$23.78 Million	$99.04 Million	+2.53pp
2008-12-31	21.48%	$15.23 Million	$70.88 Million	-4.05pp
2007-12-31	25.54%	$29.00 Million	$113.54 Million	--

pp = percentage points

About Codexis Inc

NASDAQ:CDXS USA Biotechnology

Market Cap

$97.55 Million

Market Cap Rank

#19120 Global

#4416 in USA

Share Price

$1.08

Change (1 day)

+0.00%

52-Week Range

$0.98 - $2.85

All Time High

$41.78